PMcardio

PMcardio is an AI electrocardiogram analysis platform from Powerful Medical that reads a standard 12 lead ECG and returns a structured interpretation within seconds. It identifies more than 50 findings across rhythms and arrhythmias, conduction disorders, ischemia and infarction, and interval measurements such as QTc, PR and QRS. Its Queen of Hearts model detects acute STEMI and occlusion myocardial infarction, including subtle equivalents that standard criteria miss, and LVsense flags reduced left ventricular ejection fraction from the same tracing. It is used by emergency physicians, general practitioners, nurses, paramedics and cardiologists, from the first ECG in the field through to system wide cardiac care coordination. Powerful Medical organizes the product into six suites: Acute Care, Echo Screening, Core Diagnostics, Remote Monitoring, Patient and Angio. The Queen of Hearts module holds FDA De Novo authorization and FDA Breakthrough Device designation, and the platform is CE marked as a Class IIb device under the EU MDR. Organizations can integrate with EHR and EMR systems, receive care team notifications, run an AI supported STEMI pathway and choose EU or US data residency. Pricing is published in euros. The individual Free plan allows 5 ECGs per month with no credit card. Pro is €10 per month for 50 ECGs, 12 lead digitization, 36 core diagnostics, Queen of Hearts, LVsense, ECGxplain explainability, the mobile app and email support. Teams is €2,610 per year, equivalent to €22 per user per month billed yearly, for 10 to 50 users and 1,000 ECGs per month, with web access, unlimited report history and dedicated onboarding. Organizations pricing is custom and adds unlimited reports and users, integrations and dedicated support.